Abstract
Treatment of hypothyroidism with 3,5,3'-triiodothyronine (T(3)) is controversial. A recent meta-analysis concludes that no evidence is present in favour of using T(3). However, the analysis included a mixture of different patient groups and dose-regimens.
Original language | English |
---|---|
Journal | European Journal of Endocrinology |
Volume | 161 |
Issue number | 6 |
Pages (from-to) | 895-902 |
Number of pages | 8 |
ISSN | 0804-4643 |
DOIs | |
Publication status | Published - 2009 |
Keywords
- Adolescent
- Adult
- Aged
- Antithyroid Agents
- Cross-Over Studies
- Depression
- Drug Therapy, Combination
- Female
- Humans
- Hypothyroidism
- Male
- Middle Aged
- Quality of Life
- Thyrotropin
- Thyroxine
- Triiodothyronine